Research Scientist II - Toxicology

• Req ID #: 235175
• Montreal, QC, CA
• 1st
• Full time

For 75 years, Charles River employees have worked together to help discover, develop, and safely manufacture new pharmacotherapies. When you join our family, you will have a significant impact on the health and well-being of people around the world. Regardless of your background in life sciences, finance, IT, sales, or another field, your skills will play an important role in the work we do. In return, we will help you build a career that you can be passionate about.

Job Overview

As a Research Scientist II on our toxicology team at our Senneville site, you will be responsible for planning, coordinating, and supervising study activities to ensure compliance with regulatory standards and the production of high-quality scientific results.

In this role, the main responsibilities will include:

• Execute and manage moderate to high complexity studies;
• Design, write, review, and revise study plans, amendments, and schedules to effectively structure all study-related activities;
• Supervise and coordinate all aspects of study procedures, whether performed within the department or in collaboration with external service groups;
• Monitor project scope, personnel, and equipment needs, and effectively communicate with management regarding resource planning;
• Support proposal development and project management under supervision;
• Participate in the design, development, and implementation of new procedures;
• Prepare scientific summaries and present research findings to internal and external stakeholders as needed;
• Serve as a department representative in cross-functional initiatives and communications;
• Prepare, review, and finalize preliminary and final reports documenting study procedures, data, and results clearly and accurately;
• Welcome clients, facilitate or support facility tours, and participate in meetings with clients (telephone or virtual);
• Mentor junior staff and support the training of research scientists;
• Ensure all projects are executed in accordance with Standard Operating Procedures (SOPs) and Good Laboratory Practices (GLP), while keeping up-to-date with relevant regulatory requirements.

About Safety Assessment

Charles River is a company committed to helping its partners accelerate the preclinical development of their medicines with exceptional safety assessment services, state-of-the-art facilities, and expert regulatory advice. From specialized toxicology and Investigational New Drug (IND) studies to customized solutions and full support for laboratories, our experienced team can design and execute programs that anticipate challenges and avoid bottlenecks for a smooth and efficient path to market. Approximately 300 IND studies are conducted annually at our safety assessment centers.

About Charles River

Charles River is an international contract research organization (CRO) specializing in early-phase research. We have leveraged our strong foundations in laboratory medicine and veterinary science to create a diverse portfolio of discovery and safety assessment services, compliant with Good Laboratory Practices and other standards, to provide our clients with comprehensive support from target identification to preclinical development. Charles River also offers a range of products and services to support our clients' laboratory testing and manufacturing activities. This extensive portfolio of products and services enables our clients to create a more flexible drug development model, reducing costs, increasing productivity, and improving efficiency for faster time to market.

With over 20,000 employees at 110 sites in 20 countries, we are strategically positioned to coordinate global resources and apply multidisciplinary perspectives to address our clients' unique challenges. Our client base includes international biotechnology and pharmaceutical companies, public agencies, and hospitals, teaching, and research institutions worldwide.

Charles River takes its contribution to the efforts to improve the quality of life for as many people as possible very seriously. Our mission's sense, our scientific excellence, and our determination drive us every day. We know that our work contributes to improving the health and well-being of countless men, women, and children around the world. We are proud to have contributed to the development of 86% of the medicines approved by the FDA in 2021.

For more information, visit www.criver.com.